Ani Pharmaceuticals announced that the Food and Drug Administration (FDA) has approved the Abbreviated New Drug Application (ANDA) for Polyethylene Glycol 3350 Powder for Oral Solution. Ani ...
According to Nielsen® syndicated data for the latest 52 weeks' period ending February 22, 2025, the MiraLAX® Powder for Solution, 17 grams (OTC) market 3 achieved annual sales of approximately $555.7 ...
Polyethylene glycol (PEG) 3350; pwd for reconstitution. Polyethylene glycol 3350 cleanses the bowel by induction of diarrhea. The osmotic activity of polyethylene glycol 3350, in combination with the ...
MiraLAX is an over-the-counter (OTC) laxative powder containing polyethylene glycol 3350 for use to relieve constipation. It is intended for adults and children ages 17 years and older. The ...
https://www.thehindubusinessline.com/markets/stock-markets/glenmark-launches-over-the-counter-laxative-to-compete-with-miralax/article69312141.ece Copy Glenmark ...
Glenmark Therapeutics Inc., USA (Glenmark) announced the launch of polyethylene glycol 3350, powder for solution, 17 grams/capful (OTC); compare to the active ingredient in MiraLAX powder for solution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results